MNTA – Partner Sandoz has submitted the response to the FDA on the Lovenox ANDA. <a href="http://sec.gov/Archives/edgar/data/1235010/000110465908060599/a08-24340_18k.htm" target="_blank">http://sec.gov/Archives/edgar/data/1235010/000110465908060599/a08-24340_18k.htm</a>